Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Institute for Molecular Manufacturing, Palo Alto, California, USA.
This chapter describes the negative consequences of medical technology development and commercialization that is too slow, and makes the case for an immediate large scale investment in medical nanorobots to save 52 million lives a year. It also explains the essence of nanotechnology, its life-saving applications, the engineering challenges, and the possibility of 1000-fold improvement over our current human biological abilities. Every decade that we delay development and commercialization of medical nanorobotics, half a billion people perish who could have been saved.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on